Clinical trial

Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity

NCT00709371

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-07-01

PhasePHASE2

Study timeline

Study start (unknown)2008-07-01Date precision: month

Registry last updated2012-11-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

Interventions

Zonisamide SR placebo/ bupropion SR placeboDRUG

Zonisamide SR placebo/ bupropion SR 360 mg/dayDRUG

Zonisamide SR 120 mg/day/ bupropion SR placeboDRUG

Zonisamide SR 360 mg/day/ bupropion SR placeboDRUG

Zonisamide SR 120 mg/day/ bupropion SR 360 mg/dayDRUG

Zonisamide SR 360 mg/day/ bupropion SR 360 mg/dayDRUG

Sponsors & collaborators

Orexigen Therapeutics, Inclead sponsor

Mapped research locations

BostonMassachusetts, United States1 ChicagoIllinois, United States1 DallasTexas, United States1 St LouisMissouri, United States1 MiamiFlorida, United States1 SeattleWashington, United States1 PortlandOregon, United States1 DenverColorado, United States1 CharlotteNorth Carolina, United States1 La JollaCalifornia, United States1 RaleighNorth Carolina, United States1 Baton RougeLouisiana, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00709371 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.